Expression of hPEBP4 negatively correlates with estrogen and progesterone receptors in endometrial carcinoma

Journal of B.U.ON.

Volumn 18, Issue 2, 2013, Pages 465-470

  Guo, Ting ^a   Li, Bin ^a   Gu, Chao ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Endometrial carcinoma; Estrogen receptor; Human phosphatidylethanolamine binding protein 4; Progesterone receptor

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; ESTROGEN RECEPTOR; HUMAN PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN 4; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ADULT; AGED; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 84879570911     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Amant F, Moerman P, Neven P et al. Endometrial cancer. Lancet 2005;366:491-505. (Pubitemid 41111699)
2. Pakkiri P, Lakhani S, Smart C. Current and future approach to the pathologist's assessment for targeted therapy in breast cancer. Pathology 2009;41:89-99.
3. Decruze SB, Green JA. Hormone therapy in advanced and recurrent endometrial cancer: a systematic review. Int J Gynecol Cancer 2007;17:964-978. (Pubitemid 47414814)
4. Yeung K, Seitz T, Li S et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999;401:173-177. (Pubitemid 29436321)
5. Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M, Rosner MR.Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem 2003;278:13061-13068. (Pubitemid 36800074)
6. Shemon AN, Heil GL, Granovsky AE et al. Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands. PLoS One 2010;5:e10479.
7. Wang X, Li N, Liu B et al. A novel human phosphatidylethanolamine-binding protein resists tumor necrosis factor alpha-induced apoptosis by inhibiting mitogen-activated protein kinase pathway activation and phosphatidylethanolamine externalization. J Biol Chem 2004;279:45855-45864. (Pubitemid 39491578)
8. Qiu J, Xiao J, Han C et al. Potentiation of tumor necrosis factor-alpha-induced tumor cell apoptosis by a small molecule inhibitor for anti-apoptotic protein hPEBP4. J Biol Chem 2010;285:12241-12247.
9. Liu H, Kong Q, Li B, He Y, Li P, Jia B. Expression of PEBP4 protein correlates with the invasion and metastasis of colorectal cancer. Tumour Biol 2012;33:267-273.
10. Yu GP, Huang B, Chen GQ, Wu S, Ji Y, Shen ZY. PEBP4 gene expression and its significance in invasion and metastasis of non-small cell lung cancer. Tumour Biol 2012;33:223-228.
11. Yu GP, Chen GQ, Wu S, Shen K, Ji Y. The expression of PEBP4 protein in lung squamous cell carcinoma. Tumour Biol 2011;32:1257-1263.
12. Li P, Wang X, Li N et al. Anti-apoptotic hPEBP4 silencing promotes TRAIL-induced apoptosis of human ovarian cancer cells by activating ERK and JNK pathways. Int J Mol Med 2006;18:505-510.
13. Liu H, Qiu J, Li N, Chen T, Cao X. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src. J Biol Chem 2010;285:21934-21942.
14. Snijders MP, de Goeij AF, Koudstaal J, Thunnissen EB, de Haan J, Bosman FT. Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium. J Pathol 1992;166:171-177.
15. Shabani N, Mylonas I, Jeschke U et al. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium. Anticancer Res 2007;27:2027-2033. (Pubitemid 46954720)
16. Koehler KF, Helguero LA, Haldosen LA, Warner M, Gustafsson JA. Reflections on the discovery and significance of estrogen receptor beta. Endocr Rev 2005;26:465-478. (Pubitemid 40691301)
17. Gadkar-Sable S, Shah C, Rosario G, Sachdeva G, Puri C. Progesterone receptors: various forms and functions in reproductive tissues. Front Biosci 2005;10:2118-2130. (Pubitemid 40905287)
18. Greene GL, Fitch FW, Jensen EV. Monoclonal antibodies to estrophilin: probes for the study of estrogen receptor. Proc Natl Acad Sci USA 1980;77:157-161. (Pubitemid 10142923)
19. Welshons WV, Lieberman ME, Gorski J. Nuclear localization of unoccupied oestrogen receptor. Nature 1984;307:747-749. (Pubitemid 14133948)
20. Mylonas I, Jeschke U, Shabani N et al. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR). Anticancer Res 2005;25:1679-1686. (Pubitemid 40896785)
21. Fujimoto J, Sakaguchi H, Aoki I, Toyoki H, Tamaya T. Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers. Oncology 2002;62:269-277. (Pubitemid 34639061)
22. Mylonas I, Jeschke U, Shabani N et al. Steroid receptors ERalpha, ERbeta, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium. Histol Histopathol 2007;22:169-176. (Pubitemid 46117102)
23. Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 2000;13:295-308. (Pubitemid 30207514)
24. Sivridis E, Giatromanolaki A, Koukourakis M, Anastasiadis P. Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression. Virchows Arch 2001;438:470-477. (Pubitemid 32449055)
25. Orbo A, Kaino T, Ames M, Larsen K, Pettersen I, Moe B. Prognostic markers for coexistent carcinoma in high risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction. Acta Obstet Gynecol Scand 2009;88:1234-1242.
26. Zhang Y, Wang X, Xiang Z et al. Promotion of cellular migration and apoptosis resistance by a mouse eye-specific phosphatidylethanolamine-binding protein. Int J Mol Med 2007;19:55-63.
27. Wang X, Li N, Li H et al. Silencing of human phosphatidylethanolamine- binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest. Clin Cancer Res 2005;11:7545-7553. (Pubitemid 41507717)